From the Daily Caller: The Boston’s Children’s Hospital (BCH) may be using fraudulent billing codes to ensure minors receive insurance coverage for puberty blockers, federal prosecutors suggested in a court document filed Tuesday.
The hospital has diagnosed hundreds of children with central precocious puberty (CPP) for the first time at ages 10 or older since 2015, even though 10 years old is a “normal” age for puberty, according to anonymized insurance data analyzed by the government.
The “large scale of these late diagnoses raises suspicion that BCH incorrectly diagnosed certain children with CPP in order to mislead insurance companies or others into covering puberty blockers for older children with gender dysphoria,” the government wrote in a court filing. “Misleading insurance companies or others about a patient’s diagnosis in order to obtain payment for off-label pharmaceuticals could form the basis of a federal healthcare offense,” the filing states.
Precocious puberty describes sexual development that happens before age eight for girls and before age nine for boys, BCH’s own website states.
Precocious puberty is a medical condition where children’s bodies begin to change into adult bodies much too soon, around the ages of 8 or 9. In rare cases, it can be the indication of a tumor in the brain or spinal cord, or a change in the brain that’s present at birth. This could be fluid buildup, known as hydrocephalus, or a tumor that isn’t cancer, known as a hamartoma.
If the condition is serious, medicine can stop the body from developing more until the usual age of puberty.
The Daily Caller explains that puberty blocking drugs, which can cost thousands of dollars, are approved by the Federal Drug Administration (FDA) for the the treatment of precocious puberty but not for the treatment of gender dysphoria.
Therefore, the Justice Department is suspicious that BCH is intentionally misdiagnosing minors with this medical condition (which affects children normally 8-9 years old), in order to trick insurance companies into paying for puberty blockers for older transgender patients.
The data reveals a “large spike” in “facially suspect diagnoses” of precocious puberty from 2020 to 2023, with at least one patient diagnosed at age 22.
There is “no clear explanation for why BCH would go from diagnosing almost no 11-year-olds with CPP for the years 2017-19 to diagnosing 50 11-year-old patients with CPP in 2022,” the government argued.
The Boston Children’s Hospital has brazenly promoted transgenderism for children on social media for years.
Want to start a conversation with your family and friends about #gender? Here’s how! #PrideMonth pic.twitter.com/5PCpZjVwbG
— Boston Children’s (@BostonChildrens) June 23, 2021
Do your patients have questions about their #genderidentity? Join us for the “Understanding gender identity: Answers for physicians,” webinar on July 14 at 5:30 p.m. Submit your questions in advance to [email protected]. Click ➡️ to register. https://t.co/7KBxQ8zghD pic.twitter.com/3GXfg0LxAz
— Boston Children’s (@BostonChildrens) July 13, 2021
What is #genderaffirmingcare, and why is it so important for #transgender kids and teens? Our experts weigh in. https://t.co/RD48lF47tF pic.twitter.com/w7hrjJyzwH
— Boston Children’s (@BostonChildrens) April 11, 2022
Read more from @MegEBrock and @katesrichardson here 👇https://t.co/JUJIFUecve
— Daily Caller (@DailyCaller) October 10, 2025
READ MORE from the Daily Caller.
Follow us on X (Formerly Twitter.)
The DML News App: www.X.com/DMLNewsApp